Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 23 Jun 2026 for Tango Therapeutics, Inc.. Read the official filing
Filing timeline
BuySaleRobert Azelby
Insider track record
Disclosed buys
0
Disclosed sells
1
Signal history
Robert Azelby: trading record in brief
This profile gathers the share dealings of Robert Azelby across 3 companies, led by ADC Therapeutics SA, Cardinal Health Inc and Tango Therapeutics, Inc. Between 15 March 2024 and 19 June 2026, the trades on record add up to 10 filings.
No open-market purchase appears, only 1 sale worth €19k. Other entries cover 9 share grants.
The latest filing, published on 23 June 2026, reports a share grant in Tango Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Robert Azelby
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
5,740 sharesCommon StockSEC:0001193125-26-279871:0
45,000 shares0Common SharesSEC:0001628280-26-040493:0
12,600 shares@ US$3.0836.7% of flowCommon SharesSEC:0001628280-26-040493:1
1,067 shares0Common SharesSEC:0001656998-25-000004:0
12,600 shares@ US$3.5842.7% of flowCommon SharesSEC:0001628280-25-031890:0
40,000 shares0Common SharesSEC:0001628280-25-029736:0
1,730 shares0Common SharesSEC:0000721371-24-000152:0
6,995 shares@ US$2.8920.7% of flowCommon SharesSEC:0001628280-24-028993:0
40,000 shares0Common SharesSEC:0001628280-24-028357:0
1,288 shares0Common SharesSEC:0000721371-24-000019:0
10 of 10 declarations
